Bristol-Myers Squibb stock forecast
Want to see BMY full AI Analyst Report?
Bristol-Myers Squibb (BMY) Stock Forecast & Price Target
BMY Analyst Ratings
BMY Stock 12 Month Forecast
Average Price Target
$65.74▲(10.37% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Evan Seigerman | BMO Capital | $60 | hold | 0.74%Upside | Reiterated | 11/18/26 | ||
| Emily Field | Barclays | $75 | buy | 25.92%Upside | Reiterated | 11/16/26 | ||
| Trung Huynh | RBC Capital | $64 | hold | 7.45%Upside | Reiterated | 11/05/26 | ||
| Courtney Breen | Bernstein | $61 | hold | 2.42%Upside | Reiterated | 11/02/26 | ||
| Louise Chen | Scotiabank | $60 | hold | 0.74%Upside | Reiterated | 10/30/26 | ||
| Terence Flynn | Morgan Stanley | $41→$40 | sell | -32.84%Downside | Reiterated | 10/30/26 | ||
| Mohit Bansal | Wells Fargo | $65→$60 | hold | 0.74%Upside | Reiterated | 10/30/26 | ||
| Matt Phipps | William Blair | ― | hold | ― | Reiterated | 10/29/26 | ||
| Jason Gerberry | Bank of America Securities | $66→$67 | buy | 12.49%Upside | Reiterated | 10/29/26 | ||
| Seamus Fernandez | Guggenheim | $75 | buy | 25.92%Upside | Reiterated | 10/29/26 | ||
| Carter Gould | Cantor Fitzgerald | $53 | hold | -11.01%Downside | Reiterated | 10/29/26 | ||
| David Amsellem | Piper Sandler | $78 | buy | 30.96%Upside | Reiterated | 10/27/26 | ||
| Asad Haider | Goldman Sachs | $63 | hold | 5.78%Upside | Assigned | 10/19/26 | ||
| Geoff Meacham | Citi | $70 | hold | 17.53%Upside | Reiterated | 10/13/26 | ||
| Srikripa Devarakonda | Truist Financial | $70 | buy | 17.53%Upside | Reiterated | 10/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Evan SeigermanBMO Capital | HoldReiterated$60 | 11/18/26 | 0.74%Upside | ||
| Emily FieldBarclays | BuyReiterated$75 | 11/16/26 | 25.92%Upside | ||
| Trung HuynhRBC Capital | HoldReiterated$64 | 11/05/26 | 7.45%Upside | ||
| Courtney BreenBernstein | HoldReiterated$61 | 11/02/26 | 2.42%Upside | ||
| Louise ChenScotiabank | HoldReiterated$60 | 10/30/26 | 0.74%Upside | ||
| Terence FlynnMorgan Stanley | SellReiterated$41→$40 | 10/30/26 | -32.84%Downside | ||
| Mohit BansalWells Fargo | HoldReiterated$65→$60 | 10/30/26 | 0.74%Upside | ||
| Matt PhippsWilliam Blair | HoldReiterated | 10/29/26 | ― | ||
| Jason GerberryBank of America Securities | BuyReiterated$66→$67 | 10/29/26 | 12.49%Upside | ||
| Seamus FernandezGuggenheim | BuyReiterated$75 | 10/29/26 | 25.92%Upside | ||
| Carter GouldCantor Fitzgerald | HoldReiterated$53 | 10/29/26 | -11.01%Downside | ||
| David AmsellemPiper Sandler | BuyReiterated$78 | 10/27/26 | 30.96%Upside | ||
| Asad HaiderGoldman Sachs | HoldAssigned$63 | 10/19/26 | 5.78%Upside | ||
| Geoff MeachamCiti | HoldReiterated$70 | 10/13/26 | 17.53%Upside | ||
| Srikripa DevarakondaTruist Financial | BuyReiterated$70 | 10/13/26 | 17.53%Upside |
Best Analysts Covering Bristol-Myers Squibb
Copying Srikripa Devarakonda's trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +9.36% per trade.
Copying David Amsellem's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +17.30% per trade.
Copying Srikripa Devarakonda's trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +24.78% per trade.
BMY Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 22 | 21 | 16 | 20 | 15 |
| Hold | 30 | 28 | 33 | 39 | 34 |
| Sell | 2 | 2 | 3 | 5 | 4 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 54 | 51 | 52 | 64 | 53 |
In the current month, BMY has received 15 Buy Ratings, 34 Hold Ratings, and 4 Sell Ratings. BMY average Analyst price target in the past 3 months is 65.74.
BMY Financial Forecast
BMY Earnings Forecast
Next quarter’s earnings estimate for BMY is $1.50 with a range of $1.32 to $1.65. The previous quarter’s EPS was $1.35. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
BMY Sales Forecast
Next quarter’s sales forecast for BMY is $12.66B with a range of $12.42B to $13.03B. The previous quarter’s sales results were $13.08B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

